Rare disease trials are challenging to recruit patients for, largely due to the limited patient population that’s affected. Site staff often work on multiple trials, so they may not ...
Only about 5% of rare diseases have at least one approved treatment available for affected patients. To increase the availability of care options in this therapeutic area, sponsors ...
Many vital clinical trial operations, from trial design to recruitment, depend on technology sourced through vendors. A sponsor’s choice of clinical trial technology companies and ...
Decentralized trials enable the expansion of clinical research to a wider population. To bring clinical trials outside the physical confines of a clinic, sponsors need to develop ...
Even if your clinical trial enrollment is on track, it is still worthwhile to invest in making recruitment the smoothest–and fastest–it can be. Optimizing your approach with deeper ...
While the StudyTeam® platform was originally built to empower sites to more effectively pre-screen and enroll their studies, a growing number of site teams continue to use this ...
.png?width=64&name=OST%20Transparent%20(1).png)
